I’m sure we’ve seen the stories breaking about the vaccine scandal in China, where 250,000 defective vaccines had been administered to children.
Let’s also take a moment to recall the World Health Organization’s declaration in 2014 that “China enters the global vaccine market.” The ability for these Chinese manufacturers to gain pre-approval from the WHO was largely in part thanks to… the Clinton Foundation?
But what would it take for more Chinese vaccines to be marketed outside China? Prequalification is one factor, but can be challenging for manufacturers. The Chengdu Institute of Biological Products obtained WHO prequalification for its Japanese encephalitis vaccine after years of wide-ranging technical support from nongovernmental agency PATH, which is funded by the Bill & Melinda Gates Foundation.
The Clinton Health Access Initiative (CHAI) has been working with Chinese suppliers to support their applications for WHO prequalification for several vaccine candidates for the last two years, says Joshua Chu, CHAI’s Director, Vaccines Markets.
This “Preapproved” also defined in the article
The “prequalified” stamp of approval means that these vaccines are consistently safe, effective and of high quality, and thus recommended for bulk purchase by the United Nations Children’s Fund (UNICEF) in 152 low and middle-income countries, the GAVI Alliance – which funds vaccines in 73 of these countries – and other agencies.
Let’s also not forget Clinton Foundation associates’ other notable scandals in China: